¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÅÀåÇÐȸ KSN-IAC(Integrated Academic Conference) 2022 ÅëÇÕÇмú´ëȸ(2ÀÏÂ÷) : 2022-09-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽÅÀåÇÐȸ KSN-IAC(Integrated Academic Conference) 2022 ÅëÇÕÇмú´ëȸ(2ÀÏÂ÷) : 2022-09-25
±³À°ÀÏÀÚ : 2022-09-25
±³À°Àå¼Ò : ºÎ»ê, º¤½ºÄÚ  
±³À°ÁÖÁ¦ : KSN-IAC(Integrated Academic Conference) 2022 ÅëÇÕÇмú´ëȸ(2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
´ã´çÀÚ : ´ëÇѽÅÀåÇÐȸ
¿¬¶ôó : 02-3486-8736  
À̸ÞÀÏ : ksn@ksn.or.kr      
±³À°Á¾·ù : ³»°úÀÇ»çÇÐ
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 21 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 60,000¿ø      
ºñ°í [»çÀüµî·Ï]¡á Àü¹®ÀÇ(±³¼ö,ºÀÁ÷ÀÇ,°³¿øÀÇ): 1ÀÏ-25,000/ÀüÀÏ50,000 ¡á ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç,¾à»ç,¿µ¾ç»ç,»çȸº¹Áö»ç,ÀÇ·á°ü·ÃÁ¾»çÀÚ: 1ÀÏ-10,000¿ø/ÀüÀÏ-20,000¿ø [ÇöÀåµî·Ï]¡á Àü¹®ÀÇ(±³¼ö,ºÀÁ÷ÀÇ,°³¿øÀÇ): 1ÀÏ-30,000/ÀüÀÏ60,000 ¡á ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç,¾à»ç,¿µ¾ç»ç,»çȸº¹Áö»ç,ÀÇ·á°ü·ÃÁ¾»çÀÚ: 1ÀÏ-15,000¿ø/ÀüÀÏ-30,000¿ø *¸¸65¼¼ÀÌ»óȸ¿ø, Çлý-¸éÁ¦      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-25 Room1 08:50~09:15 2021 osteoporosis guideline updates  ÀüÀ±°æ(ºÎ»ê´ëÇб³º´¿ø) 
±³À°½Ã°£ 09-25 Room1 09:15~09:40 Glucocorticoid induced osteoporosis  È²Áö¿ø(â¿ø»ï¼ºº´¿ø ·ù¸¶Æ¼½º³»°ú) 
±³À°½Ã°£ 09-25 Room1 09:40~10:05  Fracture risk assessment   ¾È½Å¿µ(°í·Á´ëÇб³ ±¸·Îº´¿ø) 
±³À°½Ã°£ 09-25 Room1 10:05~10:30  Diagnosis and management of osteoporosis in chronic kidney disease stages  ±èÈ¿Áø(ºÎ»ê´ëÇб³º´¿ø ½ÅÀå³»°ú) 
Åä·Ð 09-25 Room1 10:30~10:40 ÆгÎÅäÀÇ  ¹ÝÅÂÇöÀÌÁöÀºÃÖÇý¹Î(°¡Å縯ÀÇ´ë¿ø±¤ÀÇ´ë¸íÁöº´¿ø) 
È޽Ġ09-25 Room1 10:40~10:50 Break  () 
±³À°½Ã°£ 09-25 Room1 10:50~11:15 ¾î¸£½ÅµéÀÇ ½½±â·Î¿î Åõ¼®»ýÈ°  ¼±ÀοÀ(¿¹¼öº´¿ø) 
±³À°½Ã°£ 09-25 Room1 11:15~11:40 Åõ¼®½Ç¿¡¼­ÀÇ ÀÀ±Þ»óȲ ÀÌ·¸°Ô ÇØ°áÇϼ¼¿ä  Á¤Á¾È¯(¿ø±¤ÀÇ´ë) 
±³À°½Ã°£ 09-25 Room1 11:40~12:05 ½ÅÀåÀÌ½Ä È¯ÀÚ¿¡¼­ ²À! ¾Ë¾Æ¾ß ÇÒ °¨¿° Áúȯ  ½Åº´Ã¶(Á¶¼±ÀÇ´ë) 
±³À°½Ã°£ 09-25 Room1 12:05~12:30 º¹¸·Åõ¼®ÀÇ ÁغñºÎÅÍ ½ÇÁ¦ ó¹æ±îÁö!  ¼­»óÇå(ÀüºÏÀÇ´ë) 
½Ä»ç 09-25 Room1 12:30~13:40 ½Ä»ç  () 
±³À°½Ã°£ 09-25 Room1 13:40~14:05 Diet and CKD(Chronic Kidney Disease): What and How to Eat  ±è¼º±Ô(´ë±¸°¡Å縯´ë) 
±³À°½Ã°£ 09-25 Room1 14:05~14:30 Who and What for Newer Drugs for Diabetic Kidney Disease  ¹éÁøÇõ(°è¸íÀÇ´ë) 
±³À°½Ã°£ 09-25 Room1 14:30~14:55 Diagnosis and Treatment of CVD(cerebrovascular disease) and Heart Failure in CKD(Chronic Kidney Disease)  °­¼®ÈÖ(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 09-25 Room1 14:55~15:20 Treatment of Anemia for CKD(Chronic Kidney Disease) Patients  ÃÖÁö¿µ(°æºÏÀÇ´ë) 
Åä·Ð 09-25 Room1 15:20~15:30 ÆгÎÅäÀÇ  Á¤¼ºº¹±ÇÁø°æÀ±¿µµæ(¼ºµµ³»°úÇýÀγ»°úÀ±¿µµæ½Å¾ØÀå³»°ú) 
È޽Ġ09-25 Room1 15:30~15:40 Break  () 
±³À°½Ã°£ 09-25 Room1 15:40~16:05 °ñ´Ù°øÁõ  ±èÀ±¹Ì(ÀÎÁ¦ÀÇ´ë ºÎ»ê¹éº´¿ø) 
±³À°½Ã°£ 09-25 Room1 16:05~16:30 ´ç´¢ÁÖ»çÁ¦  ±èÀÏ¿µ(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09-25 Room1 16:30~16:55 Ç×ÀÀ°íÁ¦  ¹Ú°æ¼±(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-25 Room1 16:55~17:20 SGLT2 ¾ïÁ¦Á¦  À̼ö¹Ì(µ¿¾ÆÀÇ´ë) 
Åä·Ð 09-25 Room1 17:20~17:30 ÆгÎÅäÀÇ  Á¤°æȯÁ¶±ÔÇâ°íÀºÁ¤(°æÈñÀǴ뿵³²ÀÇ´ë°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-25 Room2 08:50~09:12 Update on latest studies on online HDF - focusing on survival benefits  ¼Û¿µ¸²(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 09-25 Room2 09:12~09:34 Update on latest studies on online HDF - focusing on other clinical benefits  ±è±âÇ¥(ÀÎÇÏÀÇ´ë) 
±³À°½Ã°£ 09-25 Room2 09:34~09:56 Removal of protein-bound uremic toxins during OL-HDF  ¹®ÁÖ¿µ(°æÈñÀÇ´ë) 
±³À°½Ã°£ 09-25 Room2 09:56~10:18 HDF mode : Pre-, Post- & Mixed-dilution HDF  ¹Ú°æ¼÷(±¹¹Îº¸Çè°ø´Ü Àϻ꺴¿ø) 
Åä·Ð 09-25 Room2 10:18~10:40 ÆгÎÅäÀÇ  ±è¾ç¿íÇÔ¿µ·ÏÀÌ¿ë±Ô(ÀÎÁ¦ÀÇ´ëÃæ³²ÀÇ´ë±¹¹Îº¸Çè°ø´Ü Àϻ꺴¿ø) 
È޽Ġ09-25 Room2 10:40~10:50 Break  () 
±³À°½Ã°£ 09-25 Room2 10:50~11:12 Optimal blood flow rate  À̹ÌÁ¤(Â÷ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 09-25 Room2 11:12~11:34 Substitution fluid : water purification, monitoring & delivery  Á¶¿µÀÏ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 09-25 Room2 11:34~11:56 Experiences of high-volume HDF in the real world (private clinic)  À±Ã¢¿¬(À±¿µ¼®³»°ú) 
±³À°½Ã°£ 09-25 Room2 11:56~12:18 Experiences of high-volume HDF in the real world (teaching hospital)  Á¶¾ÆÁø(ÇѸ²ÀÇ´ë) 
Åä·Ð 09-25 Room2 12:18~12:40 ÆгÎÅäÀÇ  ±Ç¼ø±æÁ¶Çü¾Æ±è¼º±¸(ÃæºÏÀÇ´ëÀÎÁ¦ÀǴ뱤¾ç»ç¶ûº´¿ø) 
½Ä»ç 09-25 Room2 12:40~13:40 ½Ä»ç  () 
±³À°½Ã°£ 09-25 Room2 13:40~14:05 Åõ¼®Ç÷°üÀº ¿Ö ÀÚ²Ù Á¼¾ÆÁö°í ¸·Èú±î?  ÀÌÁ¤È¯(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-25 Room2 14:05~14:30 ¾Ë¾ÆµÎ¸é ¾µ¸ðÀÖ´Â Åõ¼®Ç÷°ü °ü¸®  ±èÀºÁ¤(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 09-25 Room2 14:30~14:55 ½Ã¼ú ÀüÈÄ¿¡ Åõ¼®½Ç¿¡¼­´Â ¹«¾ùÀ» ÇؾßÇÒ±î?  ±èÇü´ö(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-25 Room2 14:55~15:20 Åõ¼®Ç÷°üÀ» »ç¿ëÇÏ´Â Åõ¼®½ÇÀÇ ÇöÁÖ¼Ò  ÀÌÁøÈ£(À̽ų»°úÀÇ¿ø) 
Åä·Ð 09-25 Room2 15:20~15:30 ÆгÎÅäÀÇ  ±è½ÂÁ¤ÀÌÁÖÇÐÁÖ³ª·¡(ÀÌÈ­ÀÇ´ë´Ã¸¼Àº³»°úÁ¦ÁÖÇѸ¶À½º´¿ø) 
È޽Ġ09-25 Room2 15:30~15:40 Break  () 
±³À°½Ã°£ 09-25 Room2 15:40~16:05 Ç÷°üÈ®Àå¼úÀÌ Åõ¼®Ç÷°ü¿¡ ³¢Ä¡´Â ¿µÇâ  ÃÖ¿ë¼±(ºÐ´çÁ¦»ýº´¿ø) 
±³À°½Ã°£ 09-25 Room2 16:05~16:30 ¼º°øÀûÀÎ ½Ã¼úÀÇ ±âÁØ°ú Åõ¼®Ç÷°üÀÇ º¯È­  ±è¼±¹Î(ÁÁÀº»ï¼±º´¿ø) 
±³À°½Ã°£ 09-25 Room2 16:30~16:55 ¾î·Á¿î ÇùÂø°ú Ç÷ÀüÁõÀÇ Ä¡·á¹æ¹ý°ú Ä¡·á½ÇÆÐ ½Ã ´ë¾ÈÀº?  ¹ÚÈƼ®(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-25 Room2 16:55~17:20 ³» ȯÀÚÀÇ Åõ¼®Ç÷°üÀº ³»°¡ ÁöŲ´Ù: ÁßÀç½ÅÀåÀÇÀÇ ¿ªÇÒ  ±¸»ó°Ç(â¿øÇѸ¶À½º´¿ø) 
Åä·Ð 09-25 Room2 17:20~17:30 ÆгÎÅäÀÇ  ±è½ÂÁ¤ÀÌÁÖÇÐÁÖ³ª·¡(ÀÌÈ­ÀÇ´ë´Ã¸¼Àº³»°úÁ¦ÁÖÇѸ¶À½º´¿ø) 
±³À°½Ã°£ 09-25 Room3 08:50~09:40 Computational image analysis for glomerular diseases  Laura Barisoni(Duke University) 
±³À°½Ã°£ 09-25 Room3 09:40~10:00 Update of Renal Pathology Research in the Era of AI  ¹ÚÁ¤È¯(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-25 Room3 10:00~10:25 Starting Deep learning-based Digital Pathology Analysis based on Transdisciplinary Team Approach  ±è¿µ°ï(¼­¿ïÀÇ´ë) 
Åä·Ð 09-25 Room3 10:25~10:40 ÆгÎÅäÀÇ  ÀÌÇÏÁ¤¹®°æö(¼­¿ïÀÇ´ë) 
È޽Ġ09-25 Room3 10:40~10:50 Break  () 
±³À°½Ã°£ 09-25 Room3 10:50~11:20 New-onset or relapsing glomerulonephritis after COVID-19 vaccination  ¹Ú¼±Èñ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 09-25 Room3 11:20~11:50 Update in pathogenesis of minimal change lesion  ÁøÈ£ÁØ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-25 Room3 11:50~12:20 Update in pathogenesis of membranous nephropathy  ±è¿¹¸²(°è¸íÀÇ´ë) 
Åä·Ð 09-25 Room3 12:20~12:40 ÆгÎÅäÀÇ  À¯¹Ì¿¬(ÇѾçÀÇ´ë) 
½Ä»ç 09-25 Room3 12:40~13:40 ½Ä»ç  () 
±³À°½Ã°£ 09-25 Room3 13:40~14:05 Current awareness of sarcopenia in KSN  ÁöÁ¾Çö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-25 Room3 14:05~14:30 Gut microbiota and sarcopenia  Â÷¶õÈñ(±¹¸³Áß¾ÓÀÇ·á¿ø) 
±³À°½Ã°£ 09-25 Room3 14:30~14:55 Phase angle and sarcopenia  ½ÅÁ¤È£(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 09-25 Room3 14:55~15:20 Gait speed and sarcopenia  Çѹ̿¬(±¹¸³Áß¾ÓÀÇ·á¿ø) 
Åä·Ð 09-25 Room3 15:20~15:30 ÆгÎÅäÀÇ  ÀÌÁ¤ÀºÃÖ¼öÁ¤¼Û¿µ¸²±è¿µÈÆ(¼º±Õ°üÀÇ´ë ¿ëÀμ¼ºê¶õ½ºº´¿ø¼øõÇâÀÇ´ëºÎõº´¿øÇѸ²ÀÇ´ëÀÎÁ¦ÀÇ´ëºÎ»ê¹éº´¿ø) 
È޽Ġ09-25 Room3 15:30~15:40 Break  () 
±³À°½Ã°£ 09-25 Room3 15:40~16:00 CUBN(Cubilin), a benign genetic cause of proteinuria  ÀÌÇö°æ(°­¿ø´ëÇб³º´¿ø) 
±³À°½Ã°£ 09-25 Room3 16:00~16:20 Dent disease of Korea  ¾çÀº¹Ì(Àü³²´ëÇб³º´¿ø) 
±³À°½Ã°£ 09-25 Room3 16:20~16:40 Anti-FGF 23 for kidney-related disease  °­Èñ°æ(¼­¿ï´ëÇб³ ¾î¸°À̺´¿ø) 
±³À°½Ã°£ 09-25 Room3 16:40~17:00 Emerging treatment of Alport syndrome  ¹èÀºÈñ(Àü³²ÀÇ´ë) 
Åä·Ð 09-25 Room3 17:00~17:30 ÆгÎÅäÀÇ  ÀÌÁÖÈÆÁ¶Èñ¿¬ÀÌÁ¤¿ø(¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø¼º±Õ°üÀÇ´ë»ï¼º¼­¿ïº´¿øÀÌÈ­ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÅÀåÇÐȸ KSN-IAC(Integrated Academic Conference) 2022 ÅëÇÕÇмú´ëȸ(2ÀÏÂ÷) : 2022-09-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦6ȸ °è¸í´ëÇб³ ÀÇ°ú´ëÇÐ Á¤Çü¿Ü°úÇб³½Ç ¾î±úÀΰø°üÀý ġȯ¼ú Ä«µ¥¹Ù¿öÅ©¼¥ : 2022-09-25
´ÙÀ½±Û ¼¼ºê¶õ½ºº´¿ø The 74th Fresh Cadaver Shoulder Arthroscopy Workshop : 2022-09-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 3 20:07:21
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 3 20:05:30
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 3 20:04:03
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 3 20:01:45
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 0 19:59:34
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 0 19:57:58
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 0 19:56:02
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 0 19:54:40
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 0 19:53:14
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 0 19:51:56
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 0 19:50:05
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 0 19:49:01
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 0 19:47:48
20880 ¼­¿ï (¿Â¶óÀÎ) 2024 ¸¶Æ÷±¸ÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-29 0 0 19:46:34
20879 ¼­¿ï Á¦10ȸ ¿ëºÀÀÇÇÐȸ Çмú´ëȸ : 2024-06-29 0 0 19:45:15
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷